VIENNA - The jury's still out on the potential dangers of gadolinium retention in the brain caused by gadolinium-based contrast agents used in MRI, according to Prof. Dr. Alexander Radbruch. He also thinks a watching brief is needed on the rising incidence of gadolinium found in wastewater and that artificial intelligence (AI) may cut gadolinium dose by 10% in the next five years.
Radbruch is chair of diagnostic and interventional neuroradiology and professor at Rheinische Friedrich Wilhelms University Bonn, Germany. His area of expertise is new MRI contrast agents, contrast agent safety, and artificial intelligence in radiology. He also holds a law degree and is interested in medicolegal issues.